TM6SF2 and hepatocellular carcinoma: Furthermore, we demonstrated that the co-presence of PNPLA3, MBOAT7 and TM6SF2 at-risk variants in 1380 MASLD subjects hugely predisposes to HCC development, highlighting the usefulness of polygenic risk scores in predicting disease severity.